437 related articles for article (PubMed ID: 30676690)
1. ALG11-CDG syndrome: Expanding the phenotype.
Haanpää MK; Ng BG; Gallant NM; Singh KE; Brown C; Kimonis V; Freeze HH; Muller EA
Am J Med Genet A; 2019 Mar; 179(3):498-502. PubMed ID: 30676690
[TBL] [Abstract][Full Text] [Related]
2. A case of ALG11-congenital disorders of glycosylation diagnosed by post-mortem whole exome sequencing.
Arai Y; Okanishi T; Kanai S; Okazaki T; Koshimizu E; Miyatake S; Maeoka Y; Fujimoto A; Matsumoto N; Maegaki Y
Brain Dev; 2022 Nov; 44(10):732-736. PubMed ID: 35907674
[TBL] [Abstract][Full Text] [Related]
3. ALG11-CDG: novel variant and review of the literature.
Erdal AE; Ceylan AC; Gücüyener K; Öktem RM; Kıreker Köylü O; Kasapkara ÇS
J Pediatr Endocrinol Metab; 2023 Apr; 36(4):409-413. PubMed ID: 36843332
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic and genotypic spectrum of congenital disorders of glycosylation type I and type II.
Al Teneiji A; Bruun TU; Sidky S; Cordeiro D; Cohn RD; Mendoza-Londono R; Moharir M; Raiman J; Siriwardena K; Kyriakopoulou L; Mercimek-Mahmutoglu S
Mol Genet Metab; 2017 Mar; 120(3):235-242. PubMed ID: 28122681
[TBL] [Abstract][Full Text] [Related]
5. Improved diagnostics lead to identification of three new patients with congenital disorder of glycosylation-Ip.
Thiel C; Rind N; Popovici D; Hoffmann GF; Hanson K; Conway RL; Adamski CR; Butler E; Scanlon R; Lambert M; Apeshiotis N; Thiels C; Matthijs G; Körner C
Hum Mutat; 2012 Mar; 33(3):485-7. PubMed ID: 22213132
[TBL] [Abstract][Full Text] [Related]
6. Complex phenotypes in ALG12-congenital disorder of glycosylation (ALG12-CDG): Case series and review of the literature.
Tahata S; Gunderson L; Lanpher B; Morava E
Mol Genet Metab; 2019 Dec; 128(4):409-414. PubMed ID: 31481313
[TBL] [Abstract][Full Text] [Related]
7. ALG12-CDG: An unusual patient without intellectual disability and facial dysmorphism, and with a novel variant.
de la Morena-Barrio ME; Sabater M; de la Morena-Barrio B; Ruhaak RL; Miñano A; Padilla J; Toderici M; Roldán V; Gimeno JR; Vicente V; Corral J
Mol Genet Genomic Med; 2020 Aug; 8(8):e1304. PubMed ID: 32530140
[TBL] [Abstract][Full Text] [Related]
8. Congenital disorder of glycosylation type Id (CDG Id): phenotypic, biochemical and molecular characterization of a new patient.
Rimella-Le-Huu A; Henry H; Kern I; Hanquinet S; Roulet-Perez E; Newman CJ; Superti-Furga A; Bonafé L; Ballhausen D
J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S381-6. PubMed ID: 18679822
[TBL] [Abstract][Full Text] [Related]
9. Guanosine diphosphate-mannose:GlcNAc2-PP-dolichol mannosyltransferase deficiency (congenital disorders of glycosylation type Ik): five new patients and seven novel mutations.
Dupré T; Vuillaumier-Barrot S; Chantret I; Sadou Yayé H; Le Bizec C; Afenjar A; Altuzarra C; Barnérias C; Burglen L; de Lonlay P; Feillet F; Napuri S; Seta N; Moore SE
J Med Genet; 2010 Nov; 47(11):729-35. PubMed ID: 20679665
[TBL] [Abstract][Full Text] [Related]
10. Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature.
Schiff M; Roda C; Monin ML; Arion A; Barth M; Bednarek N; Bidet M; Bloch C; Boddaert N; Borgel D; Brassier A; Brice A; Bruneel A; Buissonnière R; Chabrol B; Chevalier MC; Cormier-Daire V; De Barace C; De Maistre E; De Saint-Martin A; Dorison N; Drouin-Garraud V; Dupré T; Echenne B; Edery P; Feillet F; Fontan I; Francannet C; Labarthe F; Gitiaux C; Héron D; Hully M; Lamoureux S; Martin-Coignard D; Mignot C; Morin G; Pascreau T; Pincemaille O; Polak M; Roubertie A; Thauvin-Robinet C; Toutain A; Viot G; Vuillaumier-Barrot S; Seta N; De Lonlay P
J Med Genet; 2017 Dec; 54(12):843-851. PubMed ID: 28954837
[TBL] [Abstract][Full Text] [Related]
11. Toward understanding tissue-specific symptoms in dolichol-phosphate-mannose synthesis disorders; insight from DPM3-CDG.
van Tol W; Michelakakis H; Georgiadou E; van den Bergh P; Moraitou M; Papadimas GK; Papadopoulos C; Huijben K; Alsady M; Willemsen MA; Lefeber DJ
J Inherit Metab Dis; 2019 Sep; 42(5):984-992. PubMed ID: 30931530
[TBL] [Abstract][Full Text] [Related]
12. Expanding the clinical and metabolic phenotype of DPM2 deficient congenital disorders of glycosylation.
Radenkovic S; Fitzpatrick-Schmidt T; Byeon SK; Madugundu AK; Saraswat M; Lichty A; Wong SYW; McGee S; Kubiak K; Ligezka A; Ranatunga W; Zhang Y; Wood T; Friez MJ; Clarkson K; Pandey A; Jones JR; Morava E
Mol Genet Metab; 2021 Jan; 132(1):27-37. PubMed ID: 33129689
[TBL] [Abstract][Full Text] [Related]
13. MPI-CDG with transient hypoglycosylation and antithrombin deficiency.
de la Morena-Barrio ME; Wypasek E; Owczarek D; Miñano A; Vicente V; Corral J; Undas A
Haematologica; 2019 Feb; 104(2):e79-e82. PubMed ID: 30545931
[No Abstract] [Full Text] [Related]
14. Synergistic use of glycomics and single-molecule molecular inversion probes for identification of congenital disorders of glycosylation type-1.
Abu Bakar N; Ashikov A; Brum JM; Smeets R; Kersten M; Huijben K; Keng WT; Speck-Martins CE; de Carvalho DR; de Rizzo IMPO; de Mello WD; Heiner-Fokkema R; Gorman K; Grunewald S; Michelakakis H; Moraitou M; Martinelli D; van Scherpenzeel M; Janssen M; de Boer L; van den Heuvel LP; Thiel C; Lefeber DJ
J Inherit Metab Dis; 2022 Jul; 45(4):769-781. PubMed ID: 35279850
[TBL] [Abstract][Full Text] [Related]
15. DPM2-CDG: a muscular dystrophy-dystroglycanopathy syndrome with severe epilepsy.
Barone R; Aiello C; Race V; Morava E; Foulquier F; Riemersma M; Passarelli C; Concolino D; Carella M; Santorelli F; Vleugels W; Mercuri E; Garozzo D; Sturiale L; Messina S; Jaeken J; Fiumara A; Wevers RA; Bertini E; Matthijs G; Lefeber DJ
Ann Neurol; 2012 Oct; 72(4):550-8. PubMed ID: 23109149
[TBL] [Abstract][Full Text] [Related]
16. Arrest of Fetal Brain Development in ALG11-Congenital Disorder of Glycosylation.
Mulkey SB; Ng BG; Vezina GL; Bulas DI; Wolfe LA; Freeze HH; Ferreira CR
Pediatr Neurol; 2019 May; 94():64-69. PubMed ID: 30770273
[TBL] [Abstract][Full Text] [Related]
17. Defining the phenotype in congenital disorder of glycosylation due to ALG1 mutations.
Morava E; Vodopiutz J; Lefeber DJ; Janecke AR; Schmidt WM; Lechner S; Item CB; Sykut-Cegielska J; Adamowicz M; Wierzba J; Zhang ZH; Mihalek I; Stockler S; Bodamer OA; Lehle L; Wevers RA
Pediatrics; 2012 Oct; 130(4):e1034-9. PubMed ID: 22966035
[TBL] [Abstract][Full Text] [Related]
18. Congenital disorders of glycosylation: The Saudi experience.
Alsubhi S; Alhashem A; Faqeih E; Alfadhel M; Alfaifi A; Altuwaijri W; Alsahli S; Aldhalaan H; Alkuraya FS; Hundallah K; Mahmoud A; Alasmari A; Mutairi FA; Abduraouf H; AlRasheed L; Alshahwan S; Tabarki B
Am J Med Genet A; 2017 Oct; 173(10):2614-2621. PubMed ID: 28742265
[TBL] [Abstract][Full Text] [Related]
19. Congenital disorder of glycosylation due to DPM1 mutations presenting with dystroglycanopathy-type congenital muscular dystrophy.
Yang AC; Ng BG; Moore SA; Rush J; Waechter CJ; Raymond KM; Willer T; Campbell KP; Freeze HH; Mehta L
Mol Genet Metab; 2013 Nov; 110(3):345-351. PubMed ID: 23856421
[TBL] [Abstract][Full Text] [Related]
20. CDG-Id in two siblings with partially different phenotypes.
Kranz C; Sun L; Eklund EA; Krasnewich D; Casey JR; Freeze HH
Am J Med Genet A; 2007 Jul; 143A(13):1414-20. PubMed ID: 17551933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
